title: The unanswered question: what is the determinant of S-1 pharmacokinetics?
authors.forename: W
authors.initials: W
authors.lastname: Ichikawa
authors.forename: K
authors.initials: K
authors.lastname: Fujita
authors.forename: Y
authors.initials: Y
authors.lastname: Sasaki
mesh_terms: D000483:Alleles; D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D044466:Asian People / Q000235:genetics*; D049628:Body Size; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D065637:Cytochrome P-450 CYP2A6; D004338:Drug Combinations; D005472:Fluorouracil / Q000493:pharmacokinetics; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D010094:Oxonic Acid / Q000493:pharmacokinetics*; D005641:Tegafur / Q000493:pharmacokinetics*
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D001189:Aryl Hydrocarbon Hydroxylases; D065637:Cytochrome P-450 CYP2A6; D005472:Fluorouracil